MHC among first in Illinois to offer new, advanced procedure for carotid artery disease

August 24th, 2017

Memorial Hospital of Carbondale is the first and only hospital in Illinois south of Chicago to offer an innovative new treatment for patients at risk for stroke due to blockages in the neck arteries known as carotid artery disease. The minimally invasive procedure is called TransCarotid Artery Revascularization or TCAR, and involves temporarily reverses blood flow in the artery. Dangerous bits of plaque and blood clots that could dislodge and otherwise travel to the brain and cause a stroke are safely diverted away, while a dedicated transcarotid stent is inserted to open and stabilize the blockage.

SIH Medical Group Vascular and Endovascular Surgeon, Mohammed Al Zoubaidi, MD, performed the first two TCARs in MHC’s hybrid operating room in May 2017. In doing so, Dr. Al Zoubaidi became the first vascular surgeon in the state of Illinois to do so.

“TCAR is an important new option in the fight against stroke, and is particularly suited for the large portion of patients we see who are at higher risk of complications from carotid endarterectomy due to age, other medical conditions, or anatomic issues. Because of its low stroke risk, we think TCAR has the potential to become the standard of care for all patients,” said Dr. Al Zoubaidi.

The minimally invasive nature of TCAR means a quicker recovery for the patient, coupled with less pain.

“It represents the modernization of carotid repair,” said Dr. Al Zoubaidi.